184 related articles for article (PubMed ID: 3430561)
1. Increased respiratory burst of leukocytes in inflammatory bowel diseases--the analysis of free radical generation by using chemiluminescence probe.
Suematsu M; Suzuki M; Kitahora T; Miura S; Suzuki K; Hibi T; Watanabe M; Nagata H; Asakura H; Tsuchiya M
J Clin Lab Immunol; 1987 Nov; 24(3):125-8. PubMed ID: 3430561
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
3. Immunological studies on Crohn's disease. VIII. Diminished phagocytic activity in peripheral blood monocytes.
Okabe N; Ikura S; Uchida Y; Fujita K; Yao T
J Clin Lab Immunol; 1990 May; 32(1):29-31. PubMed ID: 1967033
[TBL] [Abstract][Full Text] [Related]
4. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
Griga T; Voigt E; Gretzer B; Brasch F; May B
Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
[TBL] [Abstract][Full Text] [Related]
5. Toxic oxygen metabolite production by circulating phagocytic cells in inflammatory bowel disease.
Williams JG; Hughes LE; Hallett MB
Gut; 1990 Feb; 31(2):187-93. PubMed ID: 2311976
[TBL] [Abstract][Full Text] [Related]
6. Prostanoid synthesis by cultured peripheral blood mononuclear cells in inflammatory diseases of the bowel.
Rachmilewitz D; Ligumsky M; Haimovitz A; Treves AJ
Gastroenterology; 1982 Apr; 82(4):673-9. PubMed ID: 6949849
[TBL] [Abstract][Full Text] [Related]
7. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
8. Sulfasalazine and its metabolites attenuate respiratory burst of leukocytes--a possible mechanism of anti-inflammatory effects.
Suematsu M; Suzuki M; Miura S; Nagata H; Oshio C; Asakura H; Watanabe M; Tsuchiya M
J Clin Lab Immunol; 1987 May; 23(1):31-3. PubMed ID: 2886669
[TBL] [Abstract][Full Text] [Related]
9. Re-evaluation of the phagocytic respiratory burst in the physiological or inflammatory state and in aging.
Kuroiwa A; Miyamoto K; Okabe N; Shibuya T
J Clin Lab Immunol; 1989 Aug; 29(4):189-91. PubMed ID: 2637364
[TBL] [Abstract][Full Text] [Related]
10. Differential diagnosis of intestinal Behçet's disease and Crohn's disease by colonoscopic findings.
Lee SK; Kim BK; Kim TI; Kim WH
Endoscopy; 2009 Jan; 41(1):9-16. PubMed ID: 19160153
[TBL] [Abstract][Full Text] [Related]
11. Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation.
Jenkins D; Seth R; Kummer JA; Scott BB; Hawkey CJ; Robins RA
J Pathol; 2000 Feb; 190(2):184-9. PubMed ID: 10657017
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.
Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA
Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone, colchicine and iodine-lithium-alpha-dextrin act differentially on the oxidative burst and endotoxin tolerance induction in vitro in patients with Behçet's disease.
Davtyan TK; Mkrtchyan NR; Manukyan HM; Avetisyan SA
Int Immunopharmacol; 2006 Mar; 6(3):396-407. PubMed ID: 16428075
[TBL] [Abstract][Full Text] [Related]
14. [Indications for different collagen metabolism in Crohn disease and ulcerative colitis].
Matthes H; Stallmach A; Matthes B; Herbst H; Schuppan D; Riecken EO
Med Klin (Munich); 1993 Apr; 88(4):185-92. PubMed ID: 8492773
[TBL] [Abstract][Full Text] [Related]
15. Platelet activating factor in stool from patients with ulcerative colitis and Crohn's disease.
Hocke M; Richter L; Bosseckert H; Eitner K
Hepatogastroenterology; 1999; 46(28):2333-7. PubMed ID: 10521992
[TBL] [Abstract][Full Text] [Related]
16. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
[TBL] [Abstract][Full Text] [Related]
17. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease.
Foell D; Wittkowski H; Ren Z; Turton J; Pang G; Daebritz J; Ehrchen J; Heidemann J; Borody T; Roth J; Clancy R
J Pathol; 2008 Oct; 216(2):183-92. PubMed ID: 18729068
[TBL] [Abstract][Full Text] [Related]
18. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease.
Nishida Y; Murase K; Isomoto H; Furusu H; Mizuta Y; Riddell RH; Kohno S
Hepatogastroenterology; 2002; 49(45):678-82. PubMed ID: 12063968
[TBL] [Abstract][Full Text] [Related]
19. Impaired ability of neutrophils to produce oxygen-derived free radicals in patients with chronic liver disease and hepatocellular carcinoma.
Uehara M; Sato N
Hepatology; 1994 Aug; 20(2):326-30. PubMed ID: 8045492
[TBL] [Abstract][Full Text] [Related]
20. Auto-oxidative damage in Behçet's disease--endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils.
Niwa Y; Miyake S; Sakane T; Shingu M; Yokoyama M
Clin Exp Immunol; 1982 Jul; 49(1):247-55. PubMed ID: 7127901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
